Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma

Hypoxia-activated prodrug with a quaternary ammonium function as proteoglycan-targeting ligand for a better management of chondrosarcoma: synthesis, Surface Plasmon Resonance screening, in vitro hypoxic selectivity and reductive activation.353